Unknown

Dataset Information

Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer.


ABSTRACT:

SUBMITTER: Liam CK 

PROVIDER: S-EPMC5750146 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature